1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBlavatnik Fund for Innovation at Yale is sponsored by Yale Ventures. Supports breakthrough interventions in various fields, including cardiometabolic, autoimmunity, dermatology, and oncology.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Blavatnik Fund for Innovation at Yale The Blavatnik Fund for Innovation at Yale The Blavatnik Fund for Innovation at Yale Accelerating the translation of early-stage life science research into impactful products. Blavatnik Fund for Innovation at Yale 2025 Annual Report Since 2017, Yale has supported 116 projects with over $28 million in direct funding through the Blavatnik Fund for Innovation.
The Blavatnik Fund for Innovation at Yale is a $65 million fund, committed to cultivating and transforming Yale's pioneering research into cutting-edge, life-saving solutions within the realm of life sciences. The Fund is made possible by a generous grant from the Blavatnik Family Foundation in support of the commercialization of Yale faculty applied research and technology in the life sciences.
The Fund’s integrated approach combines business expertise, intensive guidance, and essential funding to support innovative, Yale investigator-initiated translational research. Completed projects will be better positioned to positively impact human health through startup advancement, partnerships with industry, major industry-sponsored research agreements, and/or external non-dilutive funding.
Nine Breakthrough Projects Selected for 2026 Blavatnik Accelerator Awards Blavatnik Fund for Innovation at Yale to Support 12 Life Sciences Projects in 2026 Spanning Oncology, Diagnostics, Neurology, Kidney and Liver Disease Applications are now close for the Spring 2026 Accelerator Awards.
Biotech Ventures Launched Faculty that have received awards including co-PIs (105 Lead PIs) Patents associated with Blavatnik-Funded technologies FDA Investigational New Drug (IND) Status Clinical Trials Initiated $3. 4M in awards: 23 awards in 17 therapeutic areas $101M raised across all startups
According to the current listing, eligibility includes: Academic Institutions. Confirm the full requirements in the official notice before applying.
Blavatnik Fund for Innovation at Yale is funded by Yale Ventures. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleAt CGI on September 23, 2026, Global Impact Ventures committed $100 million over three years across economic opportunity, health, education, climate resilience and humanitarian needs. There is no application portal. The access route is the intermediary infrastructure — fiscal sponsorship, grantmaking administration, and a 250-organization network.
Read articleThe RFI closed June 22. Now the forum is standing up. AI Forge is a jointly governed, university-led venture funding interpretability, control, and adversarial robustness in one-year Project Ventures — here's how the 15 challenges, the CAISI tie, and the nonprofit administrator reshape who gets funded.
Read article